Pegylation Explained: What It Is & Other Drug Modifications

Pegylation is a process of covalently attaching polyethylene glycol (PEG) chains to a drug or therapeutic protein. This modification is done to improve the pharmacokinetic properties of the molecule, such as prolonging its circulation time in the body, reducing immunogenicity, and enhancing stability.

PEGylation involves attaching PEG chains to the drug or protein through various chemical reactions, resulting in the formation of a PEGylated conjugate. The PEG chains act as a protective coating around the molecule, preventing its degradation or clearance by the immune system. This modification can enhance the therapeutic efficacy and reduce side effects of the drug or protein.

Apart from pegylation, there are several other modifications that can be made to drugs or therapeutic proteins. Some of these modifications include glycosylation, acylation, lipidation, conjugation with other molecules (such as antibodies or small molecules), and engineering of specific amino acid residues. These modifications can alter the drug's properties, such as its solubility, stability, targeting ability, or half-life in the body, to improve its therapeutic potential.